Issued Patents 2022
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11529400 | Personalized immunotherapy against several neuronal and brain tumors | Sabrina Kuttruff-Coqui, Toni Weinschenk, Jens Fritsche, Steffen Walter, Norbert Hilf +2 more | 2022-12-20 |
| 11529401 | Personalized immunotherapy against several neuronal and brain tumors | Sabrina Kuttruff-Coqui, Toni Weinschenk, Jens Fritsche, Steffen Walter, Norbert Hilf +2 more | 2022-12-20 |
| 11524059 | Personalized immunotherapy against several neuronal and brain tumors | Sabrina Kuttruff-Coqui, Toni Weinschenk, Jens Fritsche, Steffen Walter, Norbert Hilf +2 more | 2022-12-13 |
| 11498948 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-11-15 |
| 11479589 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-10-25 |
| 11459365 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-10-04 |
| 11459366 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-10-04 |
| 11433124 | Peptides and combination of peptides for use in immunotherapy against various cancers | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2022-09-06 |
| 11427622 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-08-30 |
| 11414470 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-08-16 |
| 11414473 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-08-16 |
| 11414472 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-08-16 |
| 11414471 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-08-16 |
| 11407798 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-08-09 |
| 11401319 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2022-08-02 |
| 11390660 | Uterine cancer treatments | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2022-07-19 |
| 11370817 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-06-28 |
| 11359003 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2022-06-14 |
| 11352401 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-06-07 |
| 11324812 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh +2 more | 2022-05-10 |
| 11292821 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-04-05 |
| 11279741 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-03-22 |
| 11279740 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-03-22 |
| 11261224 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | Oliver Schoor, Jens Fritsche, Toni Weinschenk, Harpreet Singh | 2022-03-01 |
| 11246917 | A*03 restricted peptides for use in immunotherapy against cancers and related methods | Linus Backert, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche +2 more | 2022-02-15 |